Skip to main content
CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
41.51
+0.98 (2.42%)
At close: Jan 21, 2025, 4:00 PM
41.70
+0.19 (0.46%)
After-hours: Jan 21, 2025, 6:54 PM EST

CRISPR Therapeutics AG Revenue by Segment
Period Ending Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017
Grant
2.23M 1.71M 1.21M - - - - -
Collaboration
- - 370.00M - 170.10M 100.26M 436.00K 12.78M
Collaboration Growth
- - 84,762.39% - 1,207.15% -89.02% -99.95% -98.58%

Operating Expense Breakdown
Period Ending Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019
Research and Development
342.18M 363.57M 387.33M 395.74M 421.67M 443.34M 461.65M 461.19M
Research and Development Growth
-18.85% -17.99% -16.10% -14.19% -1.49% 14.51% 35.96% 44.66%
Collaboration
142.52M 135.02M 130.25M 117.07M 132.51M 121.80M 110.25M 135.25M
Collaboration Growth
7.55% 10.86% 18.14% -13.44% 11.49% 8.86% 8.97% 95.02%
General and Administrative
72.20M 71.76M 76.16M 80.85M 89.56M 96.80M 102.46M 104.97M
General and Administrative Growth
-19.38% -25.88% -25.67% -22.98% -11.92% -7.11% 1.74% 2.12%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.